Ethambutol Tablets BP 800 mg Manufacturer in India – Healthy Life Pharma Pvt. Ltd.

Ethambutol Tablets BP 800 mg | Manufacturer
Product image for Ethambutol Tablets BP 800 mg Manufacturer; contract manufacturing, oem & quality control.
Product Information
| Generic Name | Ethambutol |
|---|---|
| Manufacturer | Healthy Life Pharma Pvt. Ltd. |
| HSN Code | 30049053 |
| Pharmacopoeia | BP |
| Product Type | Tablet |
| Category | Antitubercular drugs |
| Subcategory | Antitubercular drugs |
| Active Ingredient | Ethambutol |
| Strength | 800 mg |
| Dosage Form | Tablet |
| Pack Size | 10 x 10 Tablets / Box (Alu-Alu / Blister) |
| Route of Administration | Oral |
| Prescription Required | Yes |
| Therapeutic Category | Antitubercular drugs |
Medicine Details & Safety
| Short Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Ethambutol Tablets BP 800 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Approved Uses / Indications | 1. First-line multidrug treatment of pulmonary and extrapulmonary tuberculosis. 2. Prophylaxis and latent tuberculosis infection management in high-risk individuals. | ||||||||||||||||||||||||
| Full Description | Healthy Life Pharma invites contract and third-party manufacturing enquiries for Ethambutol Tablets BP 800 mg from pharmaceutical marketing companies, institutional buyers and brand owners. Production specifications, batch size and packaging are agreed against the approved product dossier and purchase requirements. Product technical specifications
Product technical specifications
Manufacturing capabilities and infrastructureFor Ethambutol Tablets BP 800 mg, assess the approved formulation process, equipment suitability, batch scale and in-process controls for the Tablet presentation. Confirm environmental requirements and validated process before production.Quality control and assuranceRequest the approved finished-product specification for Ethambutol Tablets BP 800 mg, including applicable identity, assay, uniformity and performance tests for the Tablet presentation. Confirm analytical methods, acceptance criteria and batch release documentation, including COA availability.Primary and secondary packagingThe catalogue pack for Ethambutol Tablets BP 800 mg is 10 x 10 Tablets / Box (Alu-Alu / Blister). Confirm primary packaging compatibility, stability evidence, artwork, batch coding and leaflet requirements against the approved specification.Contract manufacturing and private labelSubmit the target market, strength, pharmacopoeial specification, forecast volume and brand artwork. Agree feasibility, batch size, quality agreement, production schedule and release criteria before execution. | ||||||||||||||||||||||||
| Dosage Instructions | Administer orally as a single daily dose on an empty stomach (at least 30 minutes before meals or 2 hours after meals) with water. Ensure continuous daily administration under directly observed therapy protocols. | ||||||||||||||||||||||||
| Side Effects | Common: Gastrointestinal distress, anorexia, nausea, orange-red discoloration of body fluids, mild transaminase rise. Uncommon: Peripheral neuropathy, arthralgia, headache, dizziness, cutaneous flushing. Rare: Drug-induced hepatotoxicity, optic neuritis, thrombocytopenia, hemolytic anemia. | ||||||||||||||||||||||||
| Warnings and Precautions | Hepatic Function Surveillance: Baseline and monthly liver function tests are recommended; immediately discontinue if transaminases exceed 3-5 times normal. Neuropathy Prophylaxis: Co-administer pyridoxine (vitamin B6) in patients susceptible to peripheral neuritis. Adherence: Strict uninterrupted compliance is vital to prevent MDR-TB emergence. | ||||||||||||||||||||||||
| Contraindications | 1. Hypersensitivity to Ethambutol or related hydrazide/rifamycin antimycobacterial drugs. 2. Severe acute liver disease or preexisting drug-induced hepatitis. 3. Severe peripheral neuropathy or preexisting optic neuritis (for ethambutol). | ||||||||||||||||||||||||
| Drug Interactions | 1. Potent CYP Inducers/Substrates: Rifamycin derivatives accelerate hepatic metabolism of oral contraceptives, warfarin, and protease inhibitors. 2. Antacids: Aluminum hydroxide decreases antimycobacterial absorption; space dosing by 2 hours. 3. Hepatotoxic Drugs & Alcohol: Compounded risk of severe hepatic necrosis. |
Frequently Asked Questions
| Question | Answer |
|---|---|
| Can I request third-party manufacturing for Ethambutol Tablets BP 800 mg? | Submit your brand, quantity and packaging requirements for manufacturing feasibility review. |
| Which pharmacopoeial standard applies for Ethambutol Tablets BP 800 mg? | The source specification is BP; confirm the required standard before contracting. |
| What quality tests are applicable for Ethambutol Tablets BP 800 mg? | Request the approved finished-product specification and batch testing plan. |
| Can packaging be customized for Ethambutol Tablets BP 800 mg? | Submit artwork and pack requirements for technical and regulatory review. |
| How do I request a manufacturing quotation for Ethambutol Tablets BP 800 mg? | Provide forecast volume, target market, strength and packaging requirements. |
Related Products
✚
Ethambutol Tablets BP 200 mg ExporterView product →
✚
Ethambutol Tablets BP 200 mg ManufacturerView product →
✚
Ethambutol Tablets BP 200 mg SupplierView product →
✚
Ethambutol Tablets BP 400 mg ExporterView product →
✚
Ethambutol Tablets BP 400 mg ManufacturerView product →
✚
Ethambutol Tablets BP 400 mg SupplierView product →
✚
Ethambutol Tablets BP 800 mg ExporterView product →
✚
Ethambutol Tablets BP 800 mg SupplierView product →
✚
Ethambutol Tablets IP 400 mg ExporterView product →
✚
Ethambutol Tablets IP 400 mg ManufacturerView product →
✚
Ethambutol Tablets IP 400 mg SupplierView product →
✚
Ethambutol Hydrochloride Tablets IP 200 mg ExporterView product →
